Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2022; 47(4): 815-817


Level of TNF-alpha and anti-CMV in pulmonary tuberculosis patients

Zaytoon A Alkhafaji, Ali Mahmoud Shaker, Huda Hadi Al-Hasnawy, Mohammed Mohsen, Younis Abdulridha Alkhafaji, Entisar J Al-Mukhtar.




Abstract
Cited by 0 Articles

Objective: To assess the levels of interleukins TNF-alpha in patients with pulmonary tuberculosis (pTB).
Methodology: Sixty patients with pTB who were hospitalized in the province of Hilla-Babylon provided whole blood samples from March 2019 to February 2020. The patients' ages ranged from 15 to 70 years, and there were 31 male and 29 females. TNF-alpha levels, CMV-IgG levels, and CMV-IgM levels were estimated using the ELISA method.
Results: TNF-alpha serum levels in pTB patients were substantially higher (p˂0.05) than in the healthy group (35.4) pg/ml, with an average of 68.90 pg/ml. Mean serum level of CMV-IgG was 72.44 pg/ml and was considerably higher (p˂0.05) in patients with pTB than in the healthy group (37.85 pg/ml). Mean of serum concentration of CMV-Ig M )0.153) pg/ml and was not substantially higher (p˃0.05) in individuals with pTB compared to control group (0.127) pg/ml.
Conclusion: TNF-alpha serum levels and serum level of CMV-IgG was high in pTB patients.

Key words: Pulmonary tuberculosis, TNF-α , CMV-IgG , CMV-IgM, ELISA Test.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.